Browse All / Modules / Conserved Senescence-Mediated Tumor Suppression Module

Conserved Senescence-Mediated Tumor Suppression Module

Module senescence_tumor_suppression 0 disorders Pathograph 5
A conserved tumor-suppressive module representing the original, protective arm of cellular senescence (GO:0090398): in cells at risk of malignant transformation, oncogenic, replicative, and genotoxic stress engages the p16INK4a/Rb and p53/p21 programs to impose a permanent senescence-associated arrest that halts proliferation of premalignant cells and acts as a barrier to malignant transformation. A convergent, later-life thread is the aging-associated decline of stem-cell fitness (loss of stemness), which further limits the tumor-initiating capacity of aged tissue. This module is the deliberate complement of `cellular_senescence`, which models the DELETERIOUS arm (SASP-driven accumulation and tissue dysfunction); together they capture the antagonistic pleiotropy of senescence without requiring a single effect-reversing edge. Cancer entries may reference this module as the intrinsic barrier that oncogenic transformation must evade (e.g. oncogene-induced senescence in benign nevi).
⚙

Pathophysiology Nodes

4
4 shared nodes are defined in this module.
◉

Cell Types

0
No cell types are annotated for this module.
⇄

Biological Processes

4
DNA Damage Response GO:0006974 INCREASED Cellular Senescence GO:0090398 INCREASED Negative Regulation of Cell Proliferation GO:0008285 INCREASED Stem Cell Population Maintenance GO:0019827 DECREASED
i

Notes

This is a mechanism module, not a specific disease. It models the tumor-SUPPRESSIVE mechanism of senescence/aging and is the complement of the deleterious `cellular_senescence` module; the two share the senescence-arrest concept but diverge downstream (barrier to transformation here vs. SASP/accumulation/dysfunction there). IMPORTANT framing: this module does NOT assert that aging is net-protective against cancer - older people have higher overall cancer incidence. It captures specific, conserved tumor-suppressive mechanisms (oncogene-induced/replicative senescence arrest; aging-associated loss of stemness) that operate as barriers, strongest cell-intrinsically. Disease-specific or population-level epidemiologic claims (e.g. the age-contextualized accelerated-aging/early-onset-cancer association) belong on the relevant disorder or comorbidity/trajectory entry, not here. The age/stemness arm is anchored on PMID:39633048 (Zhuang et al., Nature 2025); the senescence-barrier arm on the classic tumor-suppressive senescence literature.
↗

Used By Disorder Entries

0
No disorder entries currently reference this module via conforms_to.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Conserved Senescence-Mediated Tumor Suppression Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.
⚙

Pathophysiology

4
Oncogenic and Replicative Stress in Cells at Risk
trigger
Cells at risk of malignant transformation sustain pro-senescent stresses: activated oncogenes (oncogene-induced senescence), telomere attrition from repeated division (replicative senescence), and severe or irreparable DNA damage (genotoxic stress). Rather than tolerating these lesions, cells capable of division can route them into the senescence program.
DNA Damage Response GO:0006974 INCREASED
Downstream
  • Senescence-Associated Tumor-Suppressive Arrest
Senescence-Associated Tumor-Suppressive Arrest
central effector
The p16INK4a/Rb and p53/p21 tumor-suppressor pathways impose an essentially permanent cell-cycle arrest. By halting the proliferation of damaged or oncogene-expressing cells, this arrest is the cell-intrinsic core of senescence's tumor-suppressive function - the same arrest that, in a different (chronic, SASP-driven) context, becomes deleterious in the `cellular_senescence` module.
Cellular Senescence GO:0090398 INCREASED Negative Regulation of Cell Proliferation GO:0008285 INCREASED
Downstream
  • Barrier to Malignant Transformation
Aging-Associated Loss of Stemness
modifier
A convergent, later-life thread: aging degrades the fitness and stemness of the stem/progenitor cells of origin, reducing their capacity to initiate tumors. This is mechanistically distinct from the senescence arrest (it reflects stem-cell decline rather than p16/p53 arrest) but converges on the same tumor-suppressive outcome and supplies the age-context for this module.
Stem Cell Population Maintenance GO:0019827 DECREASED
Downstream
  • Barrier to Malignant Transformation
Barrier to Malignant Transformation
consequence
The convergent consequence: the senescence arrest and aging-associated loss of stemness together preclude clonal expansion of damaged or premalignant cells, suppressing tumor initiation. This barrier is exploited therapeutically by pro-senescent (senescence-inducing) therapies in cancer, the conceptual inverse of the senolytic strategy used against the deleterious senescence arm.